Magazine: The journey of first generics
Pharmaceutical Technology
JUNE 6, 2023
With two historic FDA approvals for RSV vaccines in the last two months, this issue’s lead interview addresses the pertinent question of access— how to ensure eligible individuals across the world get this vaccine. Please check your email to download the Report.
Let's personalize your content